Built upon a solid foundation of European research and development, K-LaserUSA has earned worldwide recognition for its therapy and treatment solutions. The K-LaserUSA development team is dedicated to offering the most advanced technologies to our clients, with a never-ending dedication to innovation. The K-Laser Class IV Therapy Lasers, as they have evolved from the D-Series to the K-Series and now to the K-Cube Series (which launched in the summer of 2012), offer comprehensive solutions with flexible architecture to keep you prepared for the challenges of the future.
The K-Laser Story of Innovation reveals how K-LaserUSA is Setting the Standard in Class IV Laser Therapy. In the 1990’s, Class IV laser therapy was established in Europe. Doctors and Clinicians utilizing laser therapy recognized the need for higher power giving higher dosages at treatment depths and shorter treatment times. Up to the end of the 20th Century, Class IV therapeutic laser technology became mainstream in Europe, and the K-Laser was introduced in Italy in 2002.
At about that time, the first Class IV therapeutic laser gained market clearance by the United States Food and Drug Administration (US FDA), and the first models of the K-Laser gained FDA clearance in March of 2005. Early adopters were quick to realize the benefits of K-Laser treatments from both a clinical and financial standpoint.
As a company, K-LaserUSA has shown steady and solid growth. And the K-Laser equipment has continued to evolve and become ‘standard of care’ in hundreds of human and animal treatment clinics across the United States. In 2007, the Zoom Handpiece was introduced, along with a 10 Watt Class IV therapy Laser. The unique and exclusive Intense Superpulse mode was developed and implemented in 2008. The following year saw the introduction of the integrated clinical handpiece, along with the launch of the K-Series.
Dr. Phil HarringtonFeb. 13, 2011